Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 Am J Emerg Med
1 Ann Transl Med
1 Arch Gynecol Obstet
1 Arch Plast Surg
1 Biochem Biophys Res Commun
1 BMC Cardiovasc Disord
1 BMC Pulm Med
1 Cell Death Dis
1 Circulation
2 Curr Opin Pulm Med
1 DNA Cell Biol
1 ESC Heart Fail
1 Eur Heart J
1 Eur J Clin Invest
1 Eur J Heart Fail
1 Front Cardiovasc Med
1 Front Immunol
1 Front Med (Lausanne)
1 Heart Lung Circ
1 Hum Gene Ther
1 Int J Mol Med
1 Interact Cardiovasc Thorac Surg
1 Intern Med J
1 J Am Heart Assoc
1 J Clin Ultrasound
1 J Hypertens
1 J Magn Reson Imaging
1 J Matern Fetal Neonatal Med
1 J Physiol
2 J Thorac Cardiovasc Surg
1 Medicine (Baltimore)
1 Neonatology
1 Pediatr Cardiol
1 Pediatr Surg Int
1 Phytomedicine
2 Pulm Circ
1 Rheumatol Int
1 Sci Rep
1 Stem Cell Res Ther
1 Thromb Res
1 Transl Res
1 Transplant Direct

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Emerg Med

  1. KOSTURA M, Smalley C, Koyfman A, Long B, et al
    Right heart failure: A narrative review for emergency clinicians.
    Am J Emerg Med. 2022;58:106-113.
    PubMed         Abstract available

    Ann Transl Med

  2. LI Q, Xin W, Ding H, Zhang Y, et al
    Total flavones from Sceptridium ternatum alleviate pulmonary hypertension through inhibiting the proliferation of vascular endothelial cells.
    Ann Transl Med. 2022;10:677.
    PubMed         Abstract available

    Arch Gynecol Obstet

  3. MING Y, Wu Z, Wu Z, Chu S, et al
    Effects of different anesthesia methods on maternal and neonatal outcomes in pregnant patients with pulmonary arterial hypertension: a meta-analysis.
    Arch Gynecol Obstet. 2022;306:7-15.
    PubMed         Abstract available

    Arch Plast Surg

  4. CASTILLO JP, Robledo AM, Torres-Canchala L, Roa-Saldarriaga L, et al
    Gigantomastia as a Cause of Pulmonary Hypertension.
    Arch Plast Surg. 2022;49:369-372.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  5. XU Y, Guo X, Ning S, He Q, et al
    Inhibition of IP3R3 attenuates endothelial to mesenchymal transition induced by TGF-beta1 through restoring mitochondrial function.
    Biochem Biophys Res Commun. 2022;619:144-150.
    PubMed         Abstract available

    BMC Cardiovasc Disord

  6. ABU T, Levi A, Hasdai D, Kramer MR, et al
    Correction to: Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization.
    BMC Cardiovasc Disord. 2022;22:324.

    BMC Pulm Med

  7. NAGATA J, Sekine A, Tanabe N, Taniguchi Y, et al
    Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
    BMC Pulm Med. 2022;22:282.
    PubMed         Abstract available

    Cell Death Dis

  8. LIU R, Xu C, Zhang W, Cao Y, et al
    FUNDC1-mediated mitophagy and HIF1alpha activation drives pulmonary hypertension during hypoxia.
    Cell Death Dis. 2022;13:634.
    PubMed         Abstract available


  9. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed         Abstract available

    Curr Opin Pulm Med

  10. KENNEDY JLW, Mihalek AD
    Update in approaches to pulmonary hypertension because of left heart disease.
    Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00013.
    PubMed         Abstract available

  11. GARCIA AR, Piccari L
    Emerging phenotypes of pulmonary hypertension associated with COPD a field guide.
    Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00012.
    PubMed         Abstract available

    DNA Cell Biol

  12. LI Y, Cai H, Wei J, Zhu L, et al
    Dihydroartemisinin Attenuates Hypoxic Pulmonary Hypertension via the Downregulation of miR-335 Targeting Vangl2.
    DNA Cell Biol. 2022 Jul 19. doi: 10.1089/dna.2021.1113.
    PubMed         Abstract available

    ESC Heart Fail

  13. SHIMBO M, Hatano M, Ishii S, Saito A, et al
    Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension.
    ESC Heart Fail. 2022;9:2728-2731.
    PubMed         Abstract available

    Eur Heart J

  14. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    PubMed         Abstract available

    Eur J Clin Invest

  15. HASAN H, Chouvarine P, Diekmann F, Diedrich N, et al
    Validation of the New Pediatric Pulmonary Hypertension Risk Score by CMR and Speckle Tracking Echocardiography.
    Eur J Clin Invest. 2022 Jul 17:e13835. doi: 10.1111/eci.13835.
    PubMed         Abstract available

    Eur J Heart Fail

  16. DANDEL M, Hetzer R
    Particular Challenges in the Use of Pulmonary Vasodilating Therapy for Patients with Pulmonary Hypertension Secondary to Left Heart Diseases.
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2622.

    Front Cardiovasc Med

  17. REZAEI-KALANTARI K, Samimi K, Zomorodian H, Bakhshandeh H, et al
    Pulmonary Blood Volume Measured by Dual-Energy Computed Tomography Can Help Distinguish Patients With Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:835655.
    PubMed         Abstract available

    Front Immunol

  18. GLUSCHKE H, Siegert E, Minich WB, Hackler J, et al
    Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
    Front Immunol. 2022;13:935787.
    PubMed         Abstract available

    Front Med (Lausanne)

  19. JIANG L, Goncharov DA, Shen Y, Lin D, et al
    Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension.
    Front Med (Lausanne). 2022;9:886868.
    PubMed         Abstract available

    Heart Lung Circ

  20. DONG C, Li Y
    Exercise Rehabilitation Training in Patients with Pulmonary Hypertension: A Review.
    Heart Lung Circ. 2022 Jul 12. pii: S1443-9506(22)00937.
    PubMed         Abstract available

    Hum Gene Ther

  21. REMES A, Korbelin J, Arnold C, Rohwedder C, et al
    AAV-mediated gene transfer of inducible nitric oxide synthase (iNOS) to an animal model of pulmonary hypertension.
    Hum Gene Ther. 2022 Jul 19. doi: 10.1089/hum.2021.
    PubMed         Abstract available

    Int J Mol Med

  22. CAO N, Aikeremu N, Shi WY, Tang XC, et al
    Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
    Int J Mol Med. 2022;50.
    PubMed         Abstract available

    Interact Cardiovasc Thorac Surg

  23. OISHI H, Matsuda Y, Ejima Y, Toyama H, et al
    Changes in haemodynamics during single lung transplantation under venovenous extracorporeal membrane oxygenation.
    Interact Cardiovasc Thorac Surg. 2022;35.
    PubMed         Abstract available

    Intern Med J

  24. CHAN RK, Horrigan M, Goh NSL, Khor YH, et al
    Clinical Assessment for Pulmonary Hypertension in Interstitial Lung Disease.
    Intern Med J. 2022 Jul 18. doi: 10.1111/imj.15887.
    PubMed         Abstract available

    J Am Heart Assoc

  25. LUTSEY PL, Evensen LH, Thenappan T, Prins KW, et al
    Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.
    J Am Heart Assoc. 2022;11:e024358.
    PubMed         Abstract available

    J Clin Ultrasound

  26. ELCIOGLU BC, Baydar O, Helvaci F, Karatas C, et al
    Evaluation of pulmonary arterial stiffness and comparison with right ventricular functions in patients with cirrhosis preparing for liver transplantation.
    J Clin Ultrasound. 2022;50:749-755.
    PubMed         Abstract available

    J Hypertens

  27. XU J, Zhong Y, Yin H, Linneman J, et al
    Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
    J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
    PubMed         Abstract available

    J Magn Reson Imaging

  28. NEZAMI N, Garg T
    Editorial for "Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension".
    J Magn Reson Imaging. 2022 Jul 18. doi: 10.1002/jmri.28361.

    J Matern Fetal Neonatal Med

  29. PRASAD CS, Kumar S, Sumathy S, Kunjukutty R, et al
    Pregnancy and pulmonary arterial hypertension-improving surveillance and outcomes with multidisciplinary care and N terminal pro-brain natriuretic peptide trends.
    J Matern Fetal Neonatal Med. 2022;35:3533-3539.
    PubMed         Abstract available

    J Physiol

  30. KARVASARSKI E, Zarathus-Cook M, Wright SP
    Catching the wave at the wrong time: Arrival timing provides additional insight into right ventricular afterload in pulmonary arterial hypertension.
    J Physiol. 2022;600:3225-3226.

    J Thorac Cardiovasc Surg

  31. SCHAFER M, Frank BS, Grady RM, Eghtesady P, et al
    Monitoring and evaluation of the surgical Potts shunt physiology using 4-dimensional flow magnetic resonance imaging.
    J Thorac Cardiovasc Surg. 2022;164:331-341.
    PubMed         Abstract available

  32. GOLDSTONE AB, Bacha EA, Rosenzweig EB
    Commentary: Keeping the reversed Potts shunt reversed: Insights from the fourth dimension.
    J Thorac Cardiovasc Surg. 2022;164:342-343.

    Medicine (Baltimore)

  33. MA G, Wang D, Xu X, Liang L, et al
    Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma.
    Medicine (Baltimore). 2022;101:e29412.
    PubMed         Abstract available


  34. BAUER-RUSEK S, Samra N, Moore SS, Arnon S, et al
    Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
    Neonatology. 2022 Jun 21:1-5. doi: 10.1159/000525128.
    PubMed         Abstract available

    Pediatr Cardiol

  35. AWAD A, Elnemr S, Hodeib H, El Amrousy D, et al
    Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Pediatr Cardiol. 2022;43:1264-1270.
    PubMed         Abstract available

    Pediatr Surg Int

  36. RAMARAJ AB, Rice-Townsend SE, Foster CL, Yung D, et al
    Trends in use of prostacyclin analogs for management of CDH-associated pulmonary hypertension.
    Pediatr Surg Int. 2022 Jul 16. pii: 10.1007/s00383-022-05176.
    PubMed         Abstract available


  37. JI L, Su S, Xin M, Zhang Z, et al
    Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2alpha-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Phytomedicine. 2022;104:154329.
    PubMed         Abstract available

    Pulm Circ

  38. ZHAI YN, Li AL, Tao XC, Xie WM, et al
    A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2022;12:e12102.
    PubMed         Abstract available

  39. HANDLER SS, Jin J, Ogawa MT, Feinstein JA, et al
    Abnormal platelet aggregation in pediatric pulmonary hypertension.
    Pulm Circ. 2022;12:e12104.
    PubMed         Abstract available

    Rheumatol Int

  40. CAETANO J, Batista F, Amaral MC, Oliveira S, et al
    Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study.
    Rheumatol Int. 2022;42:1393-1402.
    PubMed         Abstract available

    Sci Rep

  41. CAI Z, Tian S, Klein T, Tu L, et al
    Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Ralpha.
    Sci Rep. 2022;12:12326.
    PubMed         Abstract available

    Stem Cell Res Ther

  42. JIANG DT, Tuo L, Bai X, Bing WD, et al
    Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Stem Cell Res Ther. 2022;13:316.
    PubMed         Abstract available

    Thromb Res

  43. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    PubMed         Abstract available

    Transl Res

  44. RAFIKOV R, Rischard F, Vasilyev M, Varghese MV, et al
    Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex.
    Transl Res. 2022;247:1-18.
    PubMed         Abstract available

    Transplant Direct

  45. NGUYEN MC, Po-Yu Chiang T, Massie AB, Bae S, et al
    Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension.
    Transplant Direct. 2021;7:e738.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.